RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Fuji Pharma Co Stock

Fuji Pharma Co ROCE 2024

Fuji Pharma Co ROCE

0.09

Ticker

4554.T

ISIN

JP3816200004

WKN

938283

In 2024, Fuji Pharma Co's return on capital employed (ROCE) was 0.09, a -11.18% increase from the 0.11 ROCE in the previous year.

Fuji Pharma Co Aktienanalyse

What does Fuji Pharma Co do?

Fuji Pharma Co Ltd is a Japanese company specializing in the healthcare industry. The company was founded in 2001 and is headquartered in Tokyo, Japan. It is listed on the Tokyo Stock Exchange and employs over 1,000 employees. Fuji Pharma's business model is to provide its customers with innovative and high-quality products that contribute to improving health and well-being. The company specializes in several business areas, including the development, manufacturing, and marketing of pharmaceutical products, production of OEM products for other companies, and manufacturing of dietary supplements and cosmetics. An important area for Fuji Pharma is the development and production of pharmaceuticals. The company ensures that its medications meet the highest requirements and international standards. This includes research and development of new products. The company has its own research department specializing in the development of medications that can be used in serious diseases such as cancer, diabetes, and cardiovascular diseases. In addition, Fuji Pharma is also involved in the production of OEM products for other companies. The company ensures the manufacture of medications and medical products for other pharmaceutical companies, meeting the highest quality standards and customer requirements. Fuji Pharma is proud to be a trusted partner for its customers and provides its services according to the requirements of its customers. In addition to these two divisions, Fuji Pharma also produces dietary supplements and cosmetics for the domestic and international markets. These products are designed for consumers who want to improve their health and well-being. The company places great emphasis on the development of natural and safe ingredients for its products and ensures the highest standards of quality and safety. Fuji Pharma has also specialized in the Japanese market for medical devices, particularly in the field of home respiratory devices. The company has developed a new generation of respiratory therapy devices that are safe and easy to use, providing better well-being and quality of life for patients with respiratory diseases. In addition to its business areas, Fuji Pharma also has various products in its portfolio that are known for their quality and effectiveness. One such product is "Efil," a medication used in the treatment of erectile dysfunction disorders. The medication is available in Japan and other Asian countries and has already been used by over 200,000 patients. Fuji Pharma continuously strives to improve its research and development activities and develop new innovative products and services for the healthcare industry. The company aims to bring its products and services to the international market and satisfy its customers in Japan and worldwide. Fuji Pharma Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Fuji Pharma Co's Return on Capital Employed (ROCE)

Fuji Pharma Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Fuji Pharma Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Fuji Pharma Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Fuji Pharma Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Fuji Pharma Co stock

What is the ROCE (Return on Capital Employed) of Fuji Pharma Co this year?

The ROCE of Fuji Pharma Co is 0.09 undefined this year.

How has the ROCE (Return on Capital Employed) of Fuji Pharma Co developed compared to the previous year?

The ROCE of Fuji Pharma Co has increased by -11.18% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Fuji Pharma Co?

A high Return on Capital Employed (ROCE) indicates that Fuji Pharma Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Fuji Pharma Co?

A low ROCE (Return on Capital Employed) can indicate that Fuji Pharma Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Fuji Pharma Co impact the company?

An increase in the ROCE of Fuji Pharma Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Fuji Pharma Co affect the company?

A decrease in ROCE of Fuji Pharma Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Fuji Pharma Co?

Some factors that can affect Fuji Pharma Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Fuji Pharma Co so important for investors?

The ROCE of Fuji Pharma Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Fuji Pharma Co take to improve the ROCE?

To improve the ROCE, Fuji Pharma Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Fuji Pharma Co pay?

Over the past 12 months, Fuji Pharma Co paid a dividend of 37 JPY . This corresponds to a dividend yield of about 2.84 %. For the coming 12 months, Fuji Pharma Co is expected to pay a dividend of 38.86 JPY.

What is the dividend yield of Fuji Pharma Co?

The current dividend yield of Fuji Pharma Co is 2.84 %.

When does Fuji Pharma Co pay dividends?

Fuji Pharma Co pays a quarterly dividend. This is distributed in the months of April, October, April, October.

How secure is the dividend of Fuji Pharma Co?

Fuji Pharma Co paid dividends every year for the past 17 years.

What is the dividend of Fuji Pharma Co?

For the upcoming 12 months, dividends amounting to 38.86 JPY are expected. This corresponds to a dividend yield of 2.99 %.

In which sector is Fuji Pharma Co located?

Fuji Pharma Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fuji Pharma Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fuji Pharma Co from 12/1/2024 amounting to 22.5 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Fuji Pharma Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Fuji Pharma Co in the year 2023?

In the year 2023, Fuji Pharma Co distributed 35 JPY as dividends.

In which currency does Fuji Pharma Co pay out the dividend?

The dividends of Fuji Pharma Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Fuji Pharma Co

Our stock analysis for Fuji Pharma Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fuji Pharma Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.